Loss of p73 induction in a cisplatin-resistant bladder cancer cell line

Citation
Y. Ono et al., Loss of p73 induction in a cisplatin-resistant bladder cancer cell line, MOL UROL, 5(1), 2001, pp. 25-30
Citations number
24
Categorie Soggetti
Urology & Nephrology
Journal title
MOLECULAR UROLOGY
ISSN journal
10915362 → ACNP
Volume
5
Issue
1
Year of publication
2001
Pages
25 - 30
Database
ISI
SICI code
1091-5362(200121)5:1<25:LOPIIA>2.0.ZU;2-A
Abstract
Background: Cisplatin (CDDP) plays an important role in the treatment of tr ansitional-cell carcinoma (TCC), but resistance develops. The mechanism is not entirely understood. Methods: To assess acquired resistance to CDDP, we established a CDDP-resis tant subclone, CL8-2, of T24, which is a bladder cancer cell line, We exami ned the changes in the various pathways leading to apoptosis in the parent line and CL8-2, Results: The drug caused apoptosis of T24 cells but not CL8-2 cells. The CL 8-2 cells were 6.4 times more resistant to CDDP than was T24, In both cell lines, the mismatch repair genes hMLH-1 and hMSH-2 were expressed at high l evels. The p53 protein was not detected in either cell line but p73 protein was induced by CDDP treatment in T24 cells, which was followed by activati on of caspases 3, 8, and 9, This phenomenon was not observed in CL8-2 cells . Conclusion: These results suggest that loss of p73 induction may lead to CD DP resistance of TCC.